The results of the cross-sectional analysis have shown that across the years, the percentage of patients who remained untreated with systemic medications tended to increase (from almost 31% in 2017 to 40% to 2020), there was a decreasing trend in the percent of patients taking conventional therapies (from almost 52% in 2017 to 41% in 2020), and less than 20% of patients over the years were prescribed b/tsDMARDs.
← all excerpts
Analysis of the Pharmacoutilization of Biological Drugs in Psoriatic Arthritis Patients: A Real-World Retrospective Study Among an Italian Population.
1
—
—